News
Multimedia
Publication
Conferences
Resources
Subscribe
Webcasts

Spotlight -

Downstream Processing|

Upstream Processing

Biopharma Insights-Thought Leadership from Marketers | Sponsored Content | Cygnus Technologies

EP. 1: Best Practices for Quantification of Residual Host Cell DNA with Real-time PCR

ByJenna Frame, PhD, Product Marketing Manager, Cygnus Technologies,Eric Bishop, Vice President, R&D, Cygnus Technologies

February 25th 2025

EP. 2: Antibody Affinity Extraction Outperforms Native Digestion as a Sample Preparation Method for LC-MS Detection of Host Cell Proteins in Drug Substances

ByAlla Zilberman, Vice President, Technical Marketing, Cygnus Technologies, LLC ,Darren Bertin,Stephen Stahlschmidt,Johanna Barnhill,Timothy Licknack,Jared Isaac

May 20th 2024

EP. 3: Predicting Retroviral Particle Clearance with MockV® Retrovirus-like Particles

ByAlla Zilberman, Vice President, Technical Marketing, Cygnus Technologies, LLC ,David Cetlin, Senior Director, MockV Products, Cygnus Technologies, LLC

February 17th 2023

EP. 4: AAE-MS™ as an Orthogonal Method in Host Cell Protein Analytics

ByAlla Zilberman, Vice President, Technical Marketing, Cygnus Technologies, LLC

May 17th 2022

EP. 5: HCP ELISA and HCP Antibody Coverage Analysis Methods

ByAlla Zilberman, Biopharma Insights Contributor, Vice President, Technical Marketing, Cygnus Technologies

April 5th 2021

EP. 6: Predicting Viral Clearance at Your Benchtop

ByDavid Cetlin, Biopharma Insights Contributor, Senior Director of R&D at Cygnus Technologies

July 27th 2020

Viral contamination is an inherent risk during the manufacture of therapeutic products such as antibodies, vaccines, viral vectors, and plasma derivates.

Trending on BioPharm International

How India’s Biotech Ecosystem Is Shifting Toward Innovation and Global Partnerships

RNAnalytics Goes Beyond Nanoparticle Analysis at CPHI Frankfurt

© 2025 MJH Life Sciences^®

All rights reserved.